{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T11:33:40Z","timestamp":1773401620727,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,2,15]],"date-time":"2018-02-15T00:00:00Z","timestamp":1518652800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Stiftung H\u00e4motherapie-Forschung"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s00277-018-3264-2","type":"journal-article","created":{"date-parts":[[2018,2,15]],"date-time":"2018-02-15T12:50:17Z","timestamp":1518699017000},"page":"1061-1069","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Variants in FIX propeptide associated with vitamin K antagonist hypersensitivity: functional analysis and additional data confirming the common founder mutations"],"prefix":"10.1007","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4796-3424","authenticated-orcid":false,"given":"Behnaz","family":"Pezeshkpoor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrin J.","family":"Czogalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Caspers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann-Cristin","family":"Berkemeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerstin","family":"Liphardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suvoshree","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Kellner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Ulrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Pavlova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Oldenburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,15]]},"reference":[{"issue":"9025","key":"3264_CR1","first-page":"423","volume":"348","author":"G Palareti","year":"1996","unstructured":"Palareti G, Leali N, Coccheri S, Poggi M, Manotti C, D\u2019Angelo A, Pengo V, Erba N, Moia M, Ciavarella N, Devoto G, Berrettini M, Musolesi S (1996) Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy Lancet 348(9025):423\u2013428","journal-title":"Italian Study on Complications of Oral Anticoagulant Therapy Lancet"},{"issue":"2","key":"3264_CR2","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1160\/TH08-11-0730","volume":"102","author":"G Palareti","year":"2009","unstructured":"Palareti G, Cosmi B (2009) Bleeding with anticoagulation therapy\u2014who is at risk, and how best to identify such patients. Thromb Haemost 102(2):268\u2013278. https:\/\/doi.org\/10.1160\/TH08-11-0730","journal-title":"Thromb Haemost"},{"issue":"12","key":"3264_CR3","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1111\/j.1538-7836.2005.01478.x","volume":"3","author":"K Hansson","year":"2005","unstructured":"Hansson K, Stenflo J (2005) Post-translational modifications in proteins involved in blood coagulation. J Thromb Haemost 3(12):2633\u20132648. https:\/\/doi.org\/10.1111\/j.1538-7836.2005.01478.x","journal-title":"J Thromb Haemost"},{"issue":"1","key":"3264_CR4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1615\/CritRevEukaryotGeneExpr.v9.i1.50","volume":"9","author":"J Stenflo","year":"1999","unstructured":"Stenflo J (1999) Contributions of Gla and EGF-like domains to the function of vitamin K-dependent coagulation factors. Crit Rev Eukaryot Gene Expr 9(1):59\u201388","journal-title":"Crit Rev Eukaryot Gene Expr"},{"issue":"8","key":"3264_CR5","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1093\/jn\/130.8.1877","volume":"130","author":"KL Berkner","year":"2000","unstructured":"Berkner KL (2000) The vitamin K-dependent carboxylase. J Nutr 130(8):1877\u20131880. https:\/\/doi.org\/10.1093\/jn\/130.8.1877","journal-title":"J Nutr"},{"key":"3264_CR6","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0083-6729(07)00007-6","volume":"78","author":"KL Berkner","year":"2008","unstructured":"Berkner KL (2008) Vitamin K-dependent carboxylation. Vitam Horm 78:131\u2013156. https:\/\/doi.org\/10.1016\/S0083-6729(07)00007-6","journal-title":"Vitam Horm"},{"issue":"2","key":"3264_CR7","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1073\/pnas.95.2.466","volume":"95","author":"KL Berkner","year":"1998","unstructured":"Berkner KL, Pudota BN (1998) Vitamin K-dependent carboxylation of the carboxylase. Proc Natl Acad Sci U S A 95(2):466\u2013471. https:\/\/doi.org\/10.1073\/pnas.95.2.466","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"3264_CR8","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s002770050297","volume":"74","author":"EM Quenzel","year":"1997","unstructured":"Quenzel EM, Hertfelder HJ, Oldenburg J (1997) Severe bleeding in two patients due to increased sensitivity of factor IX activity to phenprocoumon therapy. Ann Hematol 74(6):265\u2013268. https:\/\/doi.org\/10.1007\/s002770050297","journal-title":"Ann Hematol"},{"issue":"1","key":"3264_CR9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1046\/j.1365-2796.1998.00252.x","volume":"243","author":"U Harbrecht","year":"1998","unstructured":"Harbrecht U, Oldenburg J, Klein P, Weber D, Rockstroh J, Hanfland P (1998) Increased sensitivity of factor IX to phenprocoumon as a cause of bleeding in a patient with antiphospholipid antibody associated thrombosis. J Intern Med 243(1):73\u201377. https:\/\/doi.org\/10.1046\/j.1365-2796.1998.00252.x","journal-title":"J Intern Med"},{"issue":"3","key":"3264_CR10","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1055\/s-0037-1615629","volume":"85","author":"J Oldenburg","year":"2001","unstructured":"Oldenburg J, Kriz K, Wuillemin WA, Maly FE, von Felten A, Siegemund A, Keeling DM, Baker P, Chu K, Konkle BA, Lammle B, Albert T (2001) Genetic predisposition to bleeding during oral anticoagulant therapy: evidence for common founder mutations (FIXVal-10 and FIXThr-10) and an independent CpG hotspot mutation (FIXThr-10). Thromb Haemost 85(3):454\u2013457","journal-title":"Thromb Haemost"},{"key":"3264_CR11","unstructured":"Ulrich S, Brand B, Speich R, Oldenburg J, Asmis L (2008) Congenital hypersensitivity to vitamin K antagonists due to FIX propeptide mutation at locus -10: a (not so) rare cause of bleeding under oral anticoagulant therapy in Switzerland. Swiss Med Wkly 138(7\u20138):100\u2013107. 2008\/07\/smw-12022"},{"issue":"2","key":"3264_CR12","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1055\/s-2001-15398","volume":"19","author":"IB Veyver Van den","year":"2001","unstructured":"Van den Veyver IB (2001) Skewed X inactivation in X-linked disorders. Semin Reprod Med 19(2):183\u2013191. https:\/\/doi.org\/10.1055\/s-2001-15398","journal-title":"Semin Reprod Med"},{"issue":"7","key":"3264_CR13","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1172\/JCI118956","volume":"98","author":"K Chu","year":"1996","unstructured":"Chu K, Wu SM, Stanley T, Stafford DW, High KA (1996) A mutation in the propeptide of factor IX leads to warfarin sensitivity by a novel mechanism. J Clin Invest 98(7):1619\u20131625. https:\/\/doi.org\/10.1172\/JCI118956","journal-title":"J Clin Invest"},{"issue":"1","key":"3264_CR14","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1046\/j.1365-2141.1997.2213036.x","volume":"98","author":"J Oldenburg","year":"1997","unstructured":"Oldenburg J, Quenzel EM, Harbrecht U, Fregin A, Kress W, Muller CR, Hertfelder HJ, Schwaab R, Brackmann HH, Hanfland P (1997) Missense mutations at ALA-10 in the factor IX propeptide: an insignificant variant in normal life but a decisive cause of bleeding during oral anticoagulant therapy. Br J Haematol 98(1):240\u2013244. https:\/\/doi.org\/10.1046\/j.1365-2141.1997.2213036.x","journal-title":"Br J Haematol"},{"issue":"3","key":"3264_CR15","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","volume":"16","author":"SA Miller","year":"1988","unstructured":"Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16(3):1215. https:\/\/doi.org\/10.1093\/nar\/16.3.1215","journal-title":"Nucleic Acids Res"},{"key":"3264_CR16","doi-asserted-by":"crossref","unstructured":"Goodeve AC, Reitsma PH, McVey JH Nomenclature of genetic variants in hemostasis. J Thromb Haemost 9(4):852\u2013855","DOI":"10.1111\/j.1538-7836.2011.04191.x"},{"issue":"5","key":"3264_CR17","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1111\/jth.12185","volume":"11","author":"A Fregin","year":"2013","unstructured":"Fregin A, Czogalla KJ, Gansler J, Rost S, Taverna M, Watzka M, Bevans CG, Muller CR, Oldenburg J (2013) A new cell culture-based assay quantifies vitamin K 2,3-epoxide reductase complex subunit 1 function and reveals warfarin resistance phenotypes not shown by the dithiothreitol-driven VKOR assay. J Thromb Haemost 11(5):872\u2013880. https:\/\/doi.org\/10.1111\/jth.12185","journal-title":"J Thromb Haemost"},{"issue":"2","key":"3264_CR18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1136\/mp.55.2.127","volume":"55","author":"DJ Bowen","year":"2002","unstructured":"Bowen DJ (2002) Haemophilia A and haemophilia B: molecular insights. Mol Pathol 55(2):127\u2013144. https:\/\/doi.org\/10.1136\/mp.55.2.127","journal-title":"Mol Pathol"},{"issue":"1","key":"3264_CR19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1365-2141.1993.tb03031.x","volume":"84","author":"PR Winship","year":"1993","unstructured":"Winship PR, Nichols CE, Chuansumrit A, Peake IR (1993) An MseI RFLP in the 5\u2032 flanking region of the factor IX gene: its use for haemophilia B carrier detection in Caucasian and Thai populations. Br J Haematol 84(1):101\u2013105. https:\/\/doi.org\/10.1111\/j.1365-2141.1993.tb03031.x","journal-title":"Br J Haematol"},{"issue":"23","key":"3264_CR20","doi-asserted-by":"publisher","first-page":"8861","DOI":"10.1093\/nar\/12.23.8861","volume":"12","author":"PR Winship","year":"1984","unstructured":"Winship PR, Anson DS, Rizza CR, Brownlee GG (1984) Carrier detection in haemophilia B using two further intragenic restriction fragment length polymorphisms. Nucleic Acids Res 12(23):8861\u20138872. https:\/\/doi.org\/10.1093\/nar\/12.23.8861","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"3264_CR21","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/j.1365-2141.1991.tb08626.x","volume":"77","author":"DJ Bowen","year":"1991","unstructured":"Bowen DJ, Thomas P, Webb CE, Bignell P, Peake IR, Bloom AL (1991) Facile and rapid analysis of three DNA polymorphisms within the human factor IX gene using the polymerase chain reaction. Br J Haematol 77(4):559\u2013560","journal-title":"Br J Haematol"},{"issue":"8639","key":"3264_CR22","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S0140-6736(89)92141-7","volume":"1","author":"PR Winship","year":"1989","unstructured":"Winship PR, Rees DJ, Alkan M (1989) Detection of polymorphisms at cytosine phosphoguanadine dinucleotides and diagnosis of haemophilia B carriers. Lancet 1(8639):631\u2013634","journal-title":"Lancet"},{"issue":"3\u20134","key":"3264_CR23","first-page":"429","volume":"71","author":"IR Peake","year":"1993","unstructured":"Peake IR, Lillicrap DP, Boulyjenkov V, Briet E, Chan V, Ginter EK, Kraus EM, Ljung R, Mannucci PM, Nicolaides K et al (1993) Haemophilia: strategies for carrier detection and prenatal diagnosis. Bull World Health Organ 71(3\u20134):429\u2013458","journal-title":"Bull World Health Organ"},{"issue":"3","key":"3264_CR24","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF02877603","volume":"20","author":"I Peake","year":"1990","unstructured":"Peake I (1990) Carrier detection and prenatal diagnosis of haemophilia. Present and future strategies. Ric Clin Lab 20(3):177\u2013185","journal-title":"Ric Clin Lab"},{"issue":"3","key":"3264_CR25","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1055\/s-0037-1615629","volume":"85","author":"L Bestmann","year":"2001","unstructured":"Bestmann L, Zuger M, Oldenburg J, Buhler D, Maly FE (2001) Coagulation factor IX propeptide mutations causing coumarin hypersensitivity: identification of female alanine-10 valine heterozygotes. Thromb Haemost 85(3):567\u2013568","journal-title":"Thromb Haemost"},{"issue":"24","key":"3264_CR26","doi-asserted-by":"publisher","first-page":"16940","DOI":"10.1074\/jbc.274.24.16940","volume":"274","author":"TB Stanley","year":"1999","unstructured":"Stanley TB, Jin DY, Lin PJ, Stafford DW (1999) The propeptides of the vitamin K-dependent proteins possess different affinities for the vitamin K-dependent carboxylase. J Biol Chem 274(24):16940\u201316944. https:\/\/doi.org\/10.1074\/jbc.274.24.16940","journal-title":"J Biol Chem"},{"issue":"2","key":"3264_CR27","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0092-8674(87)90422-3","volume":"48","author":"MJ Jorgensen","year":"1987","unstructured":"Jorgensen MJ, Cantor AB, Furie BC, Brown CL, Shoemaker CB, Furie B (1987) Recognition site directing vitamin K-dependent gamma-carboxylation resides on the propeptide of factor IX. Cell 48(2):185\u2013191. https:\/\/doi.org\/10.1016\/0092-8674(87)90422-3","journal-title":"Cell"},{"issue":"47","key":"3264_CR28","doi-asserted-by":"publisher","first-page":"15681","DOI":"10.1021\/bi991544k","volume":"38","author":"TB Stanley","year":"1999","unstructured":"Stanley TB, Humphries J, High KA, Stafford DW (1999) Amino acids responsible for reduced affinities of vitamin K-dependent propeptides for the carboxylase. Biochemistry 38(47):15681\u201315687. https:\/\/doi.org\/10.1021\/bi991544k","journal-title":"Biochemistry"},{"issue":"6","key":"3264_CR29","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/0049-3848(87)90088-0","volume":"45","author":"P Weiss","year":"1987","unstructured":"Weiss P, Soff GA, Halkin H, Seligsohn U (1987) Decline of proteins C and S and factors II, VII, IX and X during the initiation of warfarin therapy. Thromb Res 45(6):783\u2013790. https:\/\/doi.org\/10.1016\/0049-3848(87)90088-0","journal-title":"Thromb Res"},{"issue":"1","key":"3264_CR30","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1365-2141.1990.tb02542.x","volume":"74","author":"S Kumar","year":"1990","unstructured":"Kumar S, Haigh JR, Tate G, Boothby M, Joanes DN, Davies JA, Roberts BE, Feely MP (1990) Effect of warfarin on plasma concentrations of vitamin K dependent coagulation factors in patients with stable control and monitored compliance. Br J Haematol 74(1):82\u201385. https:\/\/doi.org\/10.1111\/j.1365-2141.1990.tb02542.x","journal-title":"Br J Haematol"},{"issue":"2","key":"3264_CR31","first-page":"467","volume":"99","author":"J Peters","year":"1997","unstructured":"Peters J, Luddington R, Brown K, Baglin C, Baglin T (1997) Should patients starting anticoagulant therapy be screened for missense mutations at Ala-10 in the factor IX propeptide? Br J Haematol 99(2):467\u2013468","journal-title":"Br J Haematol"},{"issue":"3","key":"3264_CR32","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1055\/s-0037-1614478","volume":"81","author":"FJ Meer van der","year":"1999","unstructured":"van der Meer FJ, Vos HL, Rosendaal FR (1999) No indication for APTT screening in patients on oral anticoagulant therapy. Thromb Haemost 81(3):364\u2013366","journal-title":"Thromb Haemost"},{"issue":"7","key":"3264_CR33","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1111\/j.1538-7836.2004.00768.x","volume":"2","author":"JF Heijden van der","year":"2004","unstructured":"van der Heijden JF, Rekke B, Hutten BA, van der Meer FJ, Remkes MG, Vermeulen M, Buller HR, Reitsma PH (2004) Non-fatal major bleeding during treatment with vitamin K antagonists: influence of soluble thrombomodulin and mutations in the propeptide of coagulation factor IX. J Thromb Haemost 2(7):1104\u20131109. https:\/\/doi.org\/10.1111\/j.1538-7836.2004.00768.x","journal-title":"J Thromb Haemost"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-018-3264-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3264-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3264-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,14]],"date-time":"2022-08-14T11:20:32Z","timestamp":1660476032000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-018-3264-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,15]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["3264"],"URL":"https:\/\/doi.org\/10.1007\/s00277-018-3264-2","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,15]]},"assertion":[{"value":"20 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individuals participating in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}